This message was sent to ##Email##. To advertise in this publication please click here

Oct. 9, 2020

SOCIETY NEWS

Introducing the Living Donor Circle of Excellence AST The AST is proud to introduce the Living Donor Circle of Excellence program! The vision for this program was inspired by the need to increase living organ donation by removing financial barriers donors sometimes encounter. Today, many employers do not offer any kind of compensation to an employee recovering from donating an organ. The Circle aims to change that. By recognizing companies who support living donation through providing salary support post-surgery, the AST envisions more people will consider this altruistic act. READ MORE

AST Partner's Blog AST Like most non-profit organizations, the AST has many valuable relationships that contribute to its continued growth and sustainability. To give our partners the opportunity to showcase their current initiatives and news, the AST posted its October 2020 Partner's Blog. READ MORE

AST Member Spotlight — Olivia Kates, MD AST Visit the AST Member Spotlight page to read about Dr. Kates. Early in the pandemic, she actively engaged other transplant professionals to establish the University of Washington COVID-19 in SOT Registry. Interested in being featured in the AST Member Spotlight? Please contact rpaulin@myast.org for more information.

SPONSORED VIDEO Kidney transplant patients share their story Watch kidney transplant patients talk about their diagnoses and the importance of communication with their doctors and transplant teams. For these patients, switching therapies made sense. See the video WATCH VIDEO

2021 Renewals Are Available Online AST As the 2020 AST membership year winds down, don't forget to renew your membership and reaffirm your commitment to the AST. Renewal invoices were distributed via email and are due December 31, 2020. If you didn't receive your email, you can log in anytime to your AST member account to view, print, and pay for your renewal. Don't miss out on all the future AST educational, networking, advocacy, and research efforts!

Flu Shot Information for Transplant Recipients and Candidates AST The AST supports the CDC's Advisory Committee on Immunization Practices recommendations that all individuals older than 6 months of age who do not have contraindications to vaccination, including those with immunocompromising conditions (including organ transplant candidates and recipients) receive a routine annual influenza vaccination. Please be aware that this recommendation applies to the general public and is especially important for health care workers and household contacts. Check out our website to view our statement and flu shot flyer. READ MORE

SPONSORED CONTENT Promoted by Natera • National Kidney Foundation CME Course: Evaluation of Acute Allograft Rejection in Kidney Transplantation • KDIGO Webinar: The Critical Role of Genetics in Kidney Disease • NEW: The Renasight Genetic Panel Can Inform the Care Path for Patients Diagnosed with CKD • Learn about Prospera for a Better Kidney Transplant Rejection Assessment • Why Prospera is the Right Choice for Managing Transplant Recipients Remotely

Survey: Acceptance Criteria for Living Donors with a History of COVID-19 AST As we move forward in these unprecedented times of the pandemic a critical question facing our transplant programs is if, when and how to safely accept living kidney donors who have recovered from COVID-19 Infection. To gain a better understanding of the magnitude and variability, in the acceptance criteria of such living donors we are seeking your responses to a brief survey. We estimate the survey will not take more than 5-10 minutes of your time. READ MORE

PRODUCT SHOWCASE The First and Only FDA-cleared digestive enzyme cartridge to Hydrolyze Fats in Enteral Formula RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients. Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula. Learn more at relizorb.com REL20-310 LEARN MORE

AST Innovation Award AST Transplantation was founded on the spirit of innovation and experimentation. The AST created the Innovation Award to honor an individual or team whose big ideas and outside the box thinking has made a significant impact on transplantation. The award is designed to showcase successes in transplant innovation and to drive, recognize, and reward novel ideas. READ MORE

COVID-19 and Transplantation: AJT Articles AST In the interest of facilitating patient care and advancing science and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all. READ MORE

SPONSOR SPOTLIGHT

AST Research Network AST The AST Research Network is now accepting applications for its annual career development grants cycle! The purpose of these grants is to foster the training of early career investigators who have the potential to contribute to transplant science/immunobiology and/or treatment of transplant recipients. The grants encourage continued commitment of high-quality applicants to their careers in transplantation. Applications are accepted in basic, clinical, and translational research. READ MORE

FEATURED ARTICLE Support specialists for kidney transplantation Promoted by Veloxis Pharmaceuticals Did you know there’s a transplant support system to help patients and providers with best-in-class assistance and resources? This ongoing support system assists with benefit investigation, prior authorization assistance, coordination with specialty pharmacies, prescription fulfillment navigation, and CoverMyMeds® access. There’s also a $0 co-pay card to overcome financial barriers. Find out more READ MORE

UPCOMING EDUCATION EVENTS

Evaluating multiple living kidney donor candidates simultaneously is more cost-effective than sequentially AST Monday, November 2, 2020 | 4 pm ET REGISTER

Disparities in Access to Transplantation AST Wednesday, November 4, 2020 | 2 pm ET VIEW NOW

See more by subscribing to our YouTube channel.

TRANSPLANT NEWS

Clinical Characteristics, Hospitalization and Mortality Rates of COVID-19 Among Liver Transplant Patients in the United States: A Multi-Center Research Network Study Gastroenterology Liver transplant (LT) patients represent one of the largest immunosuppressed cohorts. However, outcomes of COVID-19 in this population remain poorly defined although liver injury has been reported in patients with COVID-19. We sought to examine characteristics of LT patients infected with COVID-19 and study the rates of hospitalization, mortality, thrombosis, or ICU requirement in LT with COVID-19 in the U.S. READ MORE

Changes in Heart Transplant Waitlist and Post‐transplantation Outcomes in Patients with Restrictive and Hypertrophic Cardiomyopathy with the New Heart Transplant Allocation System American Journal of Transplantation Historically, patients with restrictive (RCM) and hypertrophic cardiomyopathy (HCM), experienced longer wait‐times for heart transplant (HT) and increased waitlist mortality. Recently, a new HT allocation system was implemented in the U.S. We sought to determine the impact of the new HT system on RCM/HCM patients. READ MORE

PRODUCT SHOWCASE

Now offering Mobile Phlebotomy Labs@HOME is a mobile phlebotomy in-home blood draw service to aid in specimen collection directly from a patient's home. Clinicians can order and customize a number of infectious disease and transplant-relatedtesting remotely LEARN MORE Reach Your Prospects Every Week Thousands of industry professionals subscribe to AST's eNews, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity. Connect with Highly Defined Buyers and Maximize Your Brand Exposure! LEARN MORE

Pre‐Existing Melanoma and Hematological Malignancies, Prognosis and Timing to Solid Organ Transplantation: A Consensus Expert Opinion Statement American Journal of Transplantation Patients undergoing evaluation for solid organ transplantation (SOT) frequently have a history of malignancy. Only patients with treated cancer are considered for SOT but the benefits of transplantation need to be balanced against the risk of tumor recurrence, taking into consideration the potential effects of immunosuppression. READ MORE

SPONSOR SPOTLIGHT

5-Year Single Centre Early Experience of Heart Transplantation From Donation After Circulatory Determined Death (DCD) Donors The Journal of Heart and Lung Transplantation In an effort to address the increasing demand for heart transplantation within the United Kingdom (UK) we established a clinical program of heart transplantation from donation after circulatory determined death (DCD) donors in 2015. Five years later we report the clinical early outcomes and impact of the program. READ MORE

The Impact of HLA-DR Mismatch Status on Retransplant-Free Survival and Bronchiolitis Obliterans Syndrome-Free Survival Among Sensitized Lung Transplant Recipients The Journal of Heart and Lung Transplantation Donor-recipient human leukocyte antigen (HLA)-DR locus matching may be protective against bronchiolitis obliterans syndrome (BOS) in lung transplant recipients. It is unknown whether this benefit is more significant among sensitized (CPRA>0%) and highly sensitized (CPRA≥80%) recipients, who may be at higher risk for BOS. READ MORE

AST eNews   Connect with AST Dennis Hall, Director of Publishing, 469-420-2656 | Download media kit American Society of Transplantation 1120 Route 73, Suite 200 | Mount Laurel, NJ, 08054 | 856-439-9986 | Contact Us Click here to unsubscribe. Learn how to add us to your safe sender list so our emails get to your inbox. ADVERTISE SUBSCRIBE PAST ISSUES 7701 Las Colinas Ridge, Ste. 800, Irving, TX, 75063